[SeHCAT scanning in bile acid malabsorption]. 1998

L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
Aalborg Sygehus, medicinsk gastroenterologisk afdeling.

Chronic diarrhea caused by bile acid malabsorption (BAM) is usually divided into three groups. Type 1 is associated with ileal disease or ileal resection; type 2 is idiopathic, and type 3 is BAM associated with certain predisposing conditions. We evaluated the applicability of the SeHCAT test as a routine investigation of different types of suspected BAM. Detailed information about 298 patients were obtained from retrospective review of patient records. All 68 patients with ileal resections had abnormal SeHCAT retention (median 0.6%; range 0-13%). Of 42 patients with non-resected Crohn's disease or radiation injury, BAM was found in 28 cases. A diagnosis of BAM type 2 was established in 33 of 150 patients with unexplained chronic diarrhoea. For patients tested for possible BAM type 3, the SeHCAT values were significantly lower compared to type 2 patients. For BAM type 1, the SeHCAT test is only recommended in non-resected patients. Idiopathic BAM seems to be more common than recognized. The presence of certain predisposing conditions might strengthen the indication for SeHCAT testing.

UI MeSH Term Description Entries
D007077 Ileal Diseases Pathological development in the ILEUM including the ILEOCECAL VALVE. Disease, Ileal,Diseases, Ileal,Ileal Disease
D007410 Intestinal Diseases Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM. Disease, Intestinal,Diseases, Intestinal,Intestinal Disease
D008286 Malabsorption Syndromes General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients. Malabsorption Syndrome,Syndrome, Malabsorption,Syndromes, Malabsorption
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
June 1997, Australian and New Zealand journal of medicine,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
January 1994, Gastroenterologie clinique et biologique,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
December 1992, The American journal of gastroenterology,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
January 1994, Gut,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
August 2003, Scandinavian journal of gastroenterology,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
September 2015, Alimentary pharmacology & therapeutics,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
October 2009, Alimentary pharmacology & therapeutics,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
May 2012, Nuclear medicine communications,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
September 2015, Alimentary pharmacology & therapeutics,
L H Thomsen, and A K Arveschough, and P Gustenhoff, and P Qvist
March 1985, British medical journal (Clinical research ed.),
Copied contents to your clipboard!